Picture Fairtec GmbH Worldwide Event Solutions 650x65px
Document › Details

Onxeo S.A.. (6/20/17). "Press Release: Onxeo Successfully Raises €15 Million with US and European Investors [Not for distribution in the United States, Canada, Australia and Japan]". Paris.

Organisations Organisation Onxeo S.A. (Euronext Paris, Nasdaq Copenhagen: ONXEO)
  Group Onxeo (Group)
  Group OTHER
Products Product Livatag®
  Product 2 AsiDNA™ (Onxeo / DNA Therapeutics)
Index term Index term Onxeo–SEVERAL: investment, 201706 capital increase €15m with 3.5m new shares at €4.25/share to US + European institutional investors
Persons Person Gréciet, Judith (BioAlliance Pharma 201306 CEO + France Biotech 201508 Board Member)
  Person 2 Carmagnol, Caroline (Alize RP 201107 CEO + Founder)

Record changed: 2017-06-28


Picture [LSUS] – The Business Web Portal 650x65px

More documents for Onxeo (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture Kentro Design Corporate and Web Design Berlin 650x65px

» top